SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
1-Year Return 71.55%
This Quarter Return
+29.68%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
10 Year Return
AUM
$236M
AUM Growth
+$22.4M
Cap. Flow
+$10.9M
Cap. Flow %
4.62%
Top 10 Hldgs %
41.83%
Holding
92
New
24
Increased
26
Reduced
17
Closed
14
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALT icon
51
Altimmune
ALT
$334M
$1.28M 0.43%
+100,469
New +$1.28M
NGM
52
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1.24M 0.42%
94,517
+6,214
+7% +$81.3K
CDXS icon
53
Codexis
CDXS
$218M
$881K 0.3%
145,437
+7,477
+5% +$45.3K
EYPT icon
54
EyePoint Pharmaceuticals
EYPT
$966M
$857K 0.29%
108,285
-89,355
-45% -$707K
NUVL icon
55
Nuvalent
NUVL
$5.83B
$806K 0.27%
+41,439
New +$806K
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$714K 0.24%
10,220
-26,183
-72% -$1.83M
HZNP
57
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$627K 0.21%
10,131
-62,056
-86% -$3.84M
STXS icon
58
Stereotaxis
STXS
$264M
$623K 0.21%
346,231
-22,417
-6% -$40.3K
CMPX icon
59
Compass Therapeutics
CMPX
$590M
$598K 0.2%
+262,090
New +$598K
ASND icon
60
Ascendis Pharma
ASND
$12.5B
$516K 0.17%
+5,000
New +$516K
MGTX icon
61
MeiraGTx Holdings
MGTX
$619M
$465K 0.16%
55,342
+3,276
+6% +$27.5K
MGNX icon
62
MacroGenics
MGNX
$126M
$346K 0.12%
+100,000
New +$346K
NCNA
63
NuCana
NCNA
$5.48M
$282K 0.1%
+54
New +$282K
PRAX icon
64
Praxis Precision Medicines
PRAX
$986M
$227K 0.08%
+6,667
New +$227K
ELOX
65
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$187K 0.06%
27,462
+1,425
+5% +$9.7K
EVGN icon
66
Evogene
EVGN
$10.5M
$139K 0.05%
16,751
-3,481
-17% -$28.9K
TERN icon
67
Terns Pharmaceuticals
TERN
$632M
$85K 0.03%
+14,473
New +$85K
RCOR.WS
68
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$8K ﹤0.01%
104,828
MSACW
69
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$1K ﹤0.01%
49,990
ALGS icon
70
Aligos Therapeutics
ALGS
$78.8M
-2,336
Closed -$71K
APLS icon
71
Apellis Pharmaceuticals
APLS
$3.55B
-129,795
Closed -$5.87M
AVXL icon
72
Anavex Life Sciences
AVXL
$807M
0
BIIB icon
73
Biogen
BIIB
$20.6B
-20,825
Closed -$4.25M
CGEN icon
74
Compugen
CGEN
$134M
-104,150
Closed -$193K
CLNN icon
75
Clene
CLNN
$60.2M
0